BloggingStocks http://www.bloggingstocks.com BloggingStocks http://www.blogsmithmedia.com/http://www.bloggingstocks.com/media/feedlogo.gif BloggingStocks http://www.bloggingstocks.com en-us Copyright 2012 Weblogs, Inc. The contents of this feed are available for non-commercial use only. Blogsmith http://www.blogsmith.com/<![CDATA[Edwards Lifesciences: A Heart-Felt Buy]]>http://www.bloggingstocks.com/2011/02/17/edwards-lifesciences-ew-heart-felt-buy/http://www.bloggingstocks.com/2011/02/17/edwards-lifesciences-ew-heart-felt-buy/http://www.bloggingstocks.com/2011/02/17/edwards-lifesciences-ew-heart-felt-buy/#commentsFiled under: ,

"Edwards Lifesciences (EW) is a potential winner; based in Irvine, California, Edwards makes and sells replacement valves for advanced heart disease," says growth stock specialist Alexander Green.

The editor of The Oxford Club explains, "Edwards has a breakthrough product called SAPIEN, a transcatheter valve that allows doctors to replace a heart valve without open chest surgery.

"The traditional method of replacing heart valves requires a surgeon to cut through the chest, stop the heart, remove the valve and replace it.

Continue reading Edwards Lifesciences: A Heart-Felt Buy

Edwards Lifesciences: A Heart-Felt Buy originally appeared on BloggingStocks on Thu, 17 Feb 2011 10:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>alex greenEdwards Lifesciencesfeaturedheart valve stocksmdtmedical stocksmedical technology stocksOxford ClubSAPIENsteven halpernthestockadvisors.comThu, 17 Feb 2011 10:00:00 EST<![CDATA[Best Stocks for 2008: Genomic Health (GHDX) targets cancer testing]]>http://www.bloggingstocks.com/2007/12/28/best-stocks-for-2008-genomic-health-ghdx/http://www.bloggingstocks.com/2007/12/28/best-stocks-for-2008-genomic-health-ghdx/http://www.bloggingstocks.com/2007/12/28/best-stocks-for-2008-genomic-health-ghdx/#commentsFiled under: , ,

For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.

"The era of personalized medicine is arriving and Genomic Health (NASDAQ: GHDX) is one of the first companies to provide both a successful product and an investment opportunity," says Dave Dyer in his Dave Dyer's Newsletter, referring to his more speculative favorite for 2008.

"The company's genetic test provides a way to determine whether women with early stage breast cancer would benefit from chemotherapy. For 70% of people with early stage breast cancer, minimally invasive surgery and radiation is all that is needed.

"The other 30% have a more aggressive type of cancer and would benefit from also receiving chemotherapy. An objective, quantifiable test based on the genetic characteristics of a specific patient can determine with very high probability which group a patient belongs to.

Continue reading Best Stocks for 2008: Genomic Health (GHDX) targets cancer testing

Best Stocks for 2008: Genomic Health (GHDX) targets cancer testing originally appeared on BloggingStocks on Fri, 28 Dec 2007 13:00:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>best stocks 2008BestStocks2008bizradiodave dyerdave dyer's newslettergene stocksgenetic testing stocksgenomic healthGenomicHealthghdxmedical technology stockssteven halpernthestockadvisors.comtop stocks 2008Fri, 28 Dec 2007 13:00:00 EST<![CDATA[Best Stocks for 2008: Stem cells add new market to Invitrogen (IVGN)]]>http://www.bloggingstocks.com/2007/12/27/best-stocks-for-2008-stem-cells-add-new-market-to-invitrogen-i/http://www.bloggingstocks.com/2007/12/27/best-stocks-for-2008-stem-cells-add-new-market-to-invitrogen-i/http://www.bloggingstocks.com/2007/12/27/best-stocks-for-2008-stem-cells-add-new-market-to-invitrogen-i/#commentsFiled under: , ,

For 25 years, Steven Halpern, editor of TheStockAdvisors.com, has surveyed the leading financial newsletter advisors asking for their favorite stocks for the coming year. This article is one of 100+ ideas in the Best Stocks for 2008 report.

"Our favorite speculative pick for 2008 is (NASDAQ: IVGN)," says Daniel Frishberg, editor of The MoneyMan Report and host of BizRadio.

"Invitrogen is a $4.5 billion company that markets tools in kit form and provides other research products and services to corporate, academic, and government entities. The company has over 25,000 products.

"The company is also involved in stem cells, which are cells in an early stage human embryo that have the potential to turn into any other type of cells, e.g., heart, nerve, kidney, pancreas, etc.

"There has been much debate about stem cell research due to the killing of an embryo. However, a major breakthrough suggests that stem cells can be created from your own skin cells.

Continue reading Best Stocks for 2008: Stem cells add new market to Invitrogen (IVGN)

Best Stocks for 2008: Stem cells add new market to Invitrogen (IVGN) originally appeared on BloggingStocks on Thu, 27 Dec 2007 09:15:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments]]>best stocks 2008biotech stocksbizradiodaniel frishbergDanielFrishbergfeaturedgenomic stocksinvitrogenivgnmedical products stocksmedical technology stocksmedical testing stocksstem cell stocksthe moneyman reporttop stocks 2008Thu, 27 Dec 2007 09:15:00 EST